… Aims: The aim of the meta-analysis was to assess the prevalence of comorbidities in the
COVID-19 infection patients and the risk of underlying diseases in severe patients compared to …

… In this study, we aimed to assess the prevalence of comorbidities in the confirmed COVID-19
patients. This might help showing which comorbidity might pose the patients at risk of more …

… of underlying comorbidity. In this rapid literature review we explore the prevalence of
comorbidities and associated adverse outcomes among individuals with COVID-19 and summarize …

… situation of COVID-19 cases in Indonesia. Accordingly, this study aimed to identify the current
prevalence, characteristics and comorbidities of confirmed COVID-19 cases in Indonesia. …

… The results of this study showed that the prevalence of hypertension in COVID-19 patients
(I 2 index) was 91.45% with a confidence interval of 29.0 (95%: CI: 0.22 - 0.35). It is estimated …

… In this meta-analysis, we analyzed eight different common comorbidities about their
prevalence among COVID-19 patients and found that COPD, cardio-cerebrovascular diseases, …

… Background: Since late December, 2019 an outbreak of coronavirus (COVID-19)
emerged in … the prevalence of clinical characteristics and comorbidities of coronavirus (COVID-19) …

… of comorbidities on the clinical outcomes in COVID-19 patients, our study highlights the
prevalence and impact of all possible combinations of the four most prevalent comorbidities, DM, …

… to elucidate comorbidities associated with COVID-19 disease… revealed a higher prevalence
of comorbidities in fatal cases. … a significantly higher prevalence in fatal cases of COVID-19. …

… percentage of comorbidities in the patients with COVID-19, … between comorbidities and death
in patients with COVID-19 of any age. … of comorbidities in patients with COVID-19 who died. …